Accelerate oncology evidence with trial emulation using biomarker-defined, real-world data

Traditional real-world datasets can create challenges for oncology evidence generation. Discover how Guardant Health's InfinityAI platform combines AI, multiomic, and clinical data to accelerate evidence generation and support precision oncology research. Download the white paper to explore a real-world NSCLC case study and its impact on data-driven decision-making. | Traditional real-world datasets can create challenges for oncology evidence generation. Discover how Guardant Health's InfinityAI platform combines AI, multiomic, and clinical data to accelerate evidence generation and support precision oncology research. Download the white paper to explore a real-world NSCLC case study and its impact on data-driven decision-making.